Search

Author/Creator Drozdowskyj, Ana

1. BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors. Issue 6 (December 2015)

Authors:
Gonzalez-Cao, Maria; Mayo-de-las-Casas, Clara; Molina-Vila, Miguel A.; De Mattos-Arruda, Leticia; Muñoz-Couselo, Eva; Manzano, Jose L.; Cortes, Javier; Berros, Jose P.; Drozdowskyj, Ana; Sanmamed, Miguel; Gonzalez, Alvaro; Alvarez, Carlos; Viteri, Santiago; Karachaliou, Niki; Martin Algarra, Salv...
Journal:
Melanoma research
Issue:
Volume 25:Issue 6(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC. (31st March 2017)

Authors:
Chaib, Imane; Karachaliou, Niki; Pilotto, Sara; Codony Servat, Jordi; Cai, Xueting; Li, Xuefei; Drozdowskyj, Ana; Servat, Carles Codony; Yang, Jie; Hu, Chunping; Cardona, Andres Felipe; Vivanco, Guillermo Lopez; Vergnenegre, Alain; Sanchez, Jose Miguel; Provencio, Mariano; de Marinis, Filippo; Pa...
Journal:
Journal of the National Cancer Institute
Issue:
Volume 109:Number 9(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL). (December 2020)

Authors:
Garcia-Campelo, Rosario; Arrieta, Oscar; Massuti, Bartomeu; Rodriguez-Abreu, Delvys; Granados, Ana Laura Ortega; Majem, Margarita; Vicente, David; Lianes, Pilar; Bosch-Barrera, Joaquim; Insa, Amelia; Dómine, Manuel; Reguart, Noemí; Guirado, María; Sala, María Ángeles; Vázquez-Estevez, Sergio; Car...
Journal:
Lung cancer
Issue:
Volume 150(2020)
Page Start:
62
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Early evolution of BRAFV600 status in the blood of melanoma patients correlates with clinical outcome and identifies patients refractory to therapy. Issue 3 (June 2018)

Authors:
Gonzalez-Cao, Maria; Mayo de las Casas, Clara; Jordana Ariza, Nuria; Manzano, Jose L.; Molina-Vila, Miguel Á.; Soriano, Virtudes; Puertolas, Teresa; Balada, Ariadna; Soria, Ainara; Majem, Margarita; Montagut, Clara; Muñoz, Eva; Rodriguez-Abreu, Delvys; Perez, Elisabeth; Garcia, Almudena; Cortes, ...
Journal:
Melanoma research
Issue:
Volume 28:Issue 3(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Erlotinib-associated rash in patients with EGFR mutation-positive non-small-cell lung cancer treated in the EURTAC trial. (February 2015)

Authors:
de Marinis, Filippo; Vergnenegre, Alain; Passaro, Antonio; Dubos-Arvis, Catherine; Carcereny, Enric; Drozdowskyj, Ana; Zeaiter, Ali; Perez-Moreno, Pablo; Rosell, Rafael
Journal:
Future oncology
Issue:
Volume 11:Number 3(2015)
Page Start:
421
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients. (13th January 2018)

Authors:
Karachaliou, Niki; Gonzalez-Cao, Maria; Crespo, Guillermo; Drozdowskyj, Ana; Aldeguer, Erika; Gimenez-Capitan, Ana; Teixido, Cristina; Molina-Vila, Miguel Angel; Viteri, Santiago; De Los Llanos Gil, Maria; Algarra, Salvador Martin; Perez-Ruiz, Elisabeth; Marquez-Rodas, Ivan; Rodriguez-Abreu, Delv...
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 10(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗